CVA-21 DAF

N/A

Report date: 2025/03/18 18:16:16

Base Information

Drug NameCVA-21 DAF
Drug Alias Name21 DAFv
ClassificationBiologics
Mechanisms of ActionComplement decay-accelerating factor modulators
TargetsComplement decay-accelerating factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNewcastle University
China Registration ClassN/A

Develop Information

Active CompaniesViralytics Ltd
Inactive CompaniesViroTarg Pty LtdNewcastle University
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A